OOIR: Observatory of International Research

Papers

(The TQCC of Seminars in Respiratory and Critical Care Medicine is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-12-01 to 2025-12-01.)

Article	Citations
Monographic Issue on Pulmonary Hypertension: Medical and Interventional Treatment for Chronic Thromboembolic Pulmonary Hypertension	80
Improving Medication Adherence in Asthma	77
State of the Art and Emerging Technologies in Vaccine Design for Respiratory Pathogens	56
Pneumonia After Solid Organ Transplantation	56
Sleep, Circadian Rhythms, and Lung Cancer	48
Impact of Digital Technologies on Clinical Care for Adults with Cystic Fibrosis	47
Mechanical Ventilation for COVID-19 Patients	38
Nonmalignant Pleural Effusions	37
	34
Diffuse Alveolar Hemorrhage	27
Severe Infections Due to Respiratory Viruses	27
	26
Advances in the Understanding and Management of Chronic Obstructive Pulmonary Disease	23
Prevention of Aspiration: Oral Care, Antibiotics, Others	18
Factors Influencing Glucocorticoid Treatment Response: Mechanism-Based Strategies to Overcome Glucocorticoid Resistance and Restore GRα Function	18
Indwelling Pleural Catheter: Management of Complications	17
Imaging in the Intensive Care Unit	17
Chronic Obstructive Pulmonary Disease and Work: The Continuing Narrative	17
Lung Transplant for Chronic Obstructive Pulmonary Disease	17
Fulminant Clostridioides difficile Infection: A Review of Treatment Options for a Life-Threatening Infection	17
Management of Dyspnea in Patients with Neuromuscular Disorders	16
	16
Chronic Pulmonary Aspergillosis: Clinical Presentation and Management	16
Impact of Marijuana Use on Lung Health	16
COVID-19-Related Pleural Diseases	15

Deployment-Related Respiratory Disease: Where Are We?	15
Clinical Manifestation and Treatment of Allergic Bronchopulmonary Aspergillosis	14
Antibiotic Strategies for Severe Community-Acquired Pneumonia	14
	13
The Oral–Lung Microbiome Axis in Connective Tissue Disease-Related Interstitial Lung Disease	13
Diagnostic Approach to Interstitial Lung Diseases Associated with Connective Tissue Diseases	12
Tissue Perfusion and Diffusion and Cellular Respiration: Transport and Utilization of Oxygen	12
Obstructive Sleep Apnea and Chronic Obstructive Pulmonary Disease Overlap Syndrome	12
Definition and Epidemiology of Sepsis	11
Pulmonary Physiology and Medicine of Diving	11
Update on Sepsis Epidemiology in the Era of COVID-19	11
Nocturnal Hypoxemia in Respiratory Medicine: Pathophysiology, Measurement, and Association with Outcomes	11
Management of Pulmonary Hypertension Associated with Chronic Lung Disease	11
How to Survive Sepsis: Patient Testimonial	11
Methicillin-Resistant Staphylococcus aureus Hospital-Acquired Pneumonia/Ventilator-Associated Pneumonia	11
Understanding the Updates in the Asthma Guidelines	11
Novel Therapeutic Approaches in Connective Tissue Disease-Associated Interstitial Lung Disease	10
Survivorship Challenges and Supportive Care in Lung Cancer	10
Updates in Lung Cancer Screening: A Decade of Evidence	10
Lung Cancer in Special Populations	10
Work-Related Sleep Disorders: Causes and Impacts	10
Bronchoscopic Lung Volume Reduction: A Review	10
Lung Cancer Progress and Promise: Shaping the Future of Care	10
	9
Community-Acquired Pneumonia: Postpandemic, Not Post-COVID-19	9
Beyond the Lungs—Emerging Challenges in Adult Cystic Fibrosis Care	9
Corticosteroid Treatment in Septic Shock	9
Blood Gas Transport: Implications for O2 and CO2 Exchange in Lungs and Tissues	9
Emerging Concepts in Fibroblast Biology and Progressive Pulmonary Fibrosis	9
Pertussis Vaccination: The Challenges Ahead	9
Immunopathogenesis of Sarcoidosis	9
Malignant Central Airway Obstruction: What's New?	8
Comorbid Insomnia and Sleep Apnea: From Research to Clinical Practice	8
Intra-abdominal Infections	8
Interstitial Lung Disease Associated with Systemic Sclerosis	8
Management of Acutely Decompensated Pulmonary Hypertension	8
Aspergillus and the Lung	8
Life-Threatening Infections: Pulmonary and Systemic Infections	8
Clinical Features of COVID-19 and Differentiation from Other Causes of CAP	8
Peeling Back the Layers of the Bleomycin Model of Lung Fibrosis: Lessons Learned, Factors to Consider, and Future Directions	8
Diagnosis and Management of Invasive Candida Infections in Critically Ill Patients	8
	8
Pulmonary Hypertension in Connective Tissue Diseases Other than Systemic Sclerosis	7
Arterial Blood Gases and Acid–Base Regulation	7
Glucocorticoid Treatment in Community-Acquired Pneumonia	7
Severe Community-Acquired Pneumonia	7
Sleep and Circadian-Related Outcomes after Critical Illness	7
Defining Clinical and Microbiological Nonresponse in Ventilator-Associated Pneumonia	7
Pathological Diagnosis of Pulmonary Aspergillosis	7
Severe Community-Acquired Pneumonia in Immunocompromised Patients	7

“Long Haulers”	7
Approach to Pulmonary Nodules in Connective Tissue Disease	6
Chronic Pulmonary Aspergillosis as a Considerable Complication in Post-Tuberculosis Lung Disease	6
Pseudomonas aeruginosa Pneumonia: Evolution of Antimicrobial Resistance and Implications for Therapy	6
Use of Antiviral Agents and other Therapies for COVID-19	6
Pulmonary Hypertension Associated with Left Heart Disease	6
Early Diagnosis of Sepsis: The Role of Biomarkers and Rapid Microbiological Tests	6
Advances in Disease-Modifying Therapeutics for Chronic Neuromuscular Disorders	6
HIV and COVID-19 Disease	6
Aspiration Pneumonia: Preface	6
Invasive Pulmonary Aspergillosis in Hospital and Ventilator-Associated Pneumonias	6
Viral Ventilator-Associated Pneumonia/Hospital-Acquired Pneumonia	6
Interventional Pulmonology and the Esophagus: Tracheostomy and Percutaneous Endoscopic Gastrostomy Placement	6
Imaging in Asthma Management	6
Cardiovascular Complications in Coronavirus Disease 2019—Pathogenesis and Management	6
Control of Breathing	6
Precision Medicine to Guide Obstructive Sleep Apnea Treatment Beyond the Continuous Positive Airway Pressure	6